{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-112653","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.745402+00:00","generated_at":"2026-05-16T19:51:25.254916+00:00","sec_items":["1.01","1.02","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"TELA Bio secures $70M Perceptive term loan and launches approximately $11.9M equity offering; terminates MidCap facility","bullets":["$60M initial loan funded Nov 14, 2025; optional $10M delayed draw. Matures Nov 14, 2030. Interest: 7.85% margin + greater of Reference Rate or 4.25%.","Issued Perceptive warrants for up to 2,333,333 shares at $1.11 exercise price, expiring 2035; warrants are cashless-exercisable and freely transferable.","Registered direct offering: 4,189,000 common shares and 7,523,000 pre-funded warrants at $1.11/$1.1099; expected net proceeds of ~$11.9M for general corporate purposes, closing Nov 17, 2025.","Terminated Credit & Security Agreement with MidCap Financial Trust; all MidCap security interests released.","Minimum liquidity covenant of $5.0M; revenue covenant specified in agreement; post-closing condition: company must receive at least $8.5M gross from equity offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-112653","json":"https://secwatch.observer/filing/0001104659-25-112653.json","markdown":"https://secwatch.observer/filing/0001104659-25-112653.md","text":"https://secwatch.observer/filing/0001104659-25-112653.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925112653/0001104659-25-112653-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925112653/tm2531310d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:51:25.254916+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1d827969e01f7ccee6558541aa8a274598f20a84","claim":"TELA Bio, Inc. issued up to 333,333 shares of warrant to Perceptive Credit Holdings V, LP for in connection with the Delayed Draw Loan.","evidence_excerpt":"the Company will issue to Perceptive warrants to purchase up to 333,333 shares of its Common Stock, with an exercise price of $1.11","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925112653/0001104659-25-112653-index.htm","confidence":0.98,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"up to 333,333 shares"},{"label":"Purchaser","value":"Perceptive Credit Holdings V, LP"},{"label":"Consideration","value":"in connection with the Delayed Draw Loan"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}